SCHEMBL7574784

SCHEMBL7574784

COc1ccc(NC(C(=O)O)c2ccccc2)cc1F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F2 P00734 2/20 0.47
F10 P00742 2/20 0.47
PRSS1 P07477 2/20 0.47
F7 P08709 2/20 0.47
PRSS2 P07478 1/20 0.47
F3 P13726 1/20 0.47
PRSS3 P35030 1/20 0.47
LMNA P02545 3/20 0.47
RAB9A P51151 3/20 0.47
HTT P42858 2/20 0.47
MAPK1 P28482 1/20 0.47
ALDH1A1 P00352 5/20 0.45
KDM4E B2RXH2 2/20 0.45
TDP1 Q9NUW8 1/20 0.45
MAPT P10636 4/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
NPC1 O15118 2/20 0.44
HPGD P15428 1/20 0.44
IRAK4 Q9NWZ3 1/20 0.44
MEN1 O00255 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7598789 0.85 ALDH1A1 (0.62) LMNARAB9AHTTALDH1A1KDM4E
SCHEMBL7582055 0.83 RAB9A (0.51) LMNARAB9AALDH1A1KDM4EMAPT
SCHEMBL2482554 0.82 RAB9A (0.50) LMNARAB9AHTTMAPK1KDM4E
SCHEMBL13240816 0.82 RAB9A (0.50) LMNARAB9AHTTMAPK1KDM4E
Hydrochloric Acid SCHEMBL2485885 0.81 RAB9A (0.49) LMNARAB9AHTTMAPK1KDM4E
SCHEMBL7576269 0.80 FPR2 (0.41) LMNARAB9AKDM4EMAPTSMN1; SMN2
SCHEMBL7582686 0.79 KMT2A (0.66) F2F10PRSS1F7PRSS2
SCHEMBL5882888 0.78 MEN1 (0.46) F2F10PRSS1F7PRSS2
SCHEMBL7576130 0.77 NPC1 (0.56) LMNARAB9AHTTALDH1A1KDM4E
SCHEMBL5883095 0.77 F7 (0.67) F2F10PRSS1F7PRSS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1242069-A2 ALBUMIN-BINDING COMPOUNDS THAT PREVENT NONENZYMATIC GLYCATION AND THAT MAY BE USED FOR TREATMENT OF GLYCATION-RELATED PATHOLOGIES EXOCELL, INC. (US) 2002-09-25 EP disclosed
WO-2001003684-A2 ALBUMIN-BINDING COMPOUNDS THAT PREVENT NONENZYMATIC GLYCATION AND THAT MAY BE USED FOR TREATMENT OF GLYCATION-RELATED PATHOLOGIES EXOCELL, INC. (US) 2001-01-18 WO disclosed